How Much Does NMN/NR Cost in Arkansas in 2026?

Cash-Pay Pricing Across Arkansas Pharmacies

The average out-of-pocket cost for prescription-grade NMN at Arkansas retail pharmacies sits near $80 per month in 2026 for a 250 mg once-daily capsule. Prices vary by city, pharmacy type, and whether the product is compounded or dispensed as a pre-manufactured formulation.

Little Rock pharmacies tend to cluster near the state average, while smaller markets like Jonesboro and Fayetteville can run $10 to $15 higher per month due to fewer compounding options. NR (nicotinamide riboside), sold commercially as Niagen, sits lower at roughly $40 to $60 per month because it retains its dietary supplement classification and faces broader retail competition [1]. That price difference matters. A patient taking 300 mg of NR daily from a chain pharmacy or online retailer will spend $480 to $720 per year, compared to $960 or more for compounded NMN at the same dose equivalent.

Sublingual NMN formulations, which bypass first-pass metabolism and may increase bioavailability, cost more. Expect $90 to $130 per month from Arkansas 503A pharmacies offering sublingual troches or tablets. The price premium reflects compounding labor and the specialized base materials required for sublingual delivery [2].

Bulk purchasing shifts the math. Several online compounding pharmacies licensed in Arkansas offer 90-day supplies at a 10% to 20% discount, bringing the effective monthly cost to $65 to $72 for standard capsules. Always verify that the pharmacy holds a valid Arkansas State Board of Pharmacy 503A license before ordering.

Why NMN Pricing Is Complicated: The FDA Regulatory Split

NMN occupies an unusual regulatory position that directly affects what Arkansas residents pay. In November 2022, the FDA ruled that NMN could not be marketed as a dietary supplement because it was under investigation as a new drug by Metro International Biotech [3]. This decision removed NMN from the supplement aisle but did not make it an FDA-approved prescription medication either.

The result is a regulatory gap. NMN is neither an approved drug with an established NDC code nor a freely sold supplement. Arkansas patients who want pharmaceutical-grade NMN must obtain it through a compounding pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act, which requires a valid patient-specific prescription [4]. This is legal in Arkansas. The state permits 503A compounding, and multiple pharmacies in Little Rock, Bentonville, and Hot Springs currently compound NMN capsules and sublingual formulations.

NR does not share this problem. Nicotinamide riboside (sold as Niagen by ChromaDex) maintained its Generally Recognized as Safe (GRAS) status and remains available without a prescription at CVS, Walgreens, and independent supplement retailers throughout the state [5]. This regulatory distinction explains the price gap: NR benefits from supplement-market competition, while NMN pricing reflects compounding costs, prescription requirements, and a smaller number of suppliers.

Arkansas Medicaid Coverage: Limited Prior Authorization

Arkansas Medicaid lists NMN/NR under a limited prior authorization pathway, but approval rates are extremely low. The program does not include NMN on its preferred drug list, and there is no established Medicaid reimbursement rate for compounded nicotinamide mononucleotide.

To obtain PA approval, a prescriber must document a specific clinical indication tied to NAD+ metabolism. Pellagra (niacin deficiency), certain mitochondrial disorders, and rare inborn errors of NAD+ biosynthesis are the most likely candidates for approval. "Anti-aging" or "longevity optimization" indications will be denied. Arkansas Medicaid follows CMS guidelines that exclude experimental or investigational uses from coverage, and NMN for age-related NAD+ decline falls squarely into that category as of 2026.

The practical path for Medicaid-enrolled patients who want NAD+ precursor support is over-the-counter NR, which requires no prescription and no prior authorization. At $40 to $60 per month, NR represents the lowest-cost entry point for patients on fixed incomes. A 2018 randomized trial by Martens et al. (N=24) found that NR supplementation at 1 to 000 mg daily for six weeks raised NAD+ levels by approximately 60% in healthy older adults with no serious adverse events [6]. That study provides reasonable clinical evidence for NR as an NAD+ booster, even if the sample size was small.

Commercial Insurance: No Coverage in 2026

No major commercial health insurer operating in Arkansas (Blue Cross Blue Shield of Arkansas, Ambetter, QualChoice, or UnitedHealthcare) covers NMN or NR as a pharmacy benefit in 2026. The reasons are straightforward. NMN lacks FDA approval as a drug, so it has no NDC billing code in standard pharmacy claims systems. NR is classified as a supplement and falls outside prescription drug formularies.

Some patients have attempted to route NMN through medical benefit claims (rather than pharmacy benefit claims) by framing it as a compounded medication for a diagnosed condition. Success rates are low. Without a recognized FDA-approved indication, most Arkansas insurers will deny the claim at the utilization review stage.

Health Savings Account (HSA) and Flexible Spending Account (FSA) funds present a partial workaround. The IRS permits HSA/FSA reimbursement for items prescribed by a physician to treat a specific medical condition. If an Arkansas provider writes a prescription for compounded NMN to treat a documented diagnosis (not a wellness goal), the patient may be able to pay with pre-tax HSA/FSA dollars. This effectively reduces the cost by the patient's marginal tax rate, saving $15 to $25 per month for someone in the 22% to 24% federal bracket [7].

Compounded NMN in Arkansas: Legality and Quality

Compounded nicotinamide mononucleotide is legal in Arkansas through 503A pharmacies. These pharmacies must hold a current license from the Arkansas State Board of Pharmacy and comply with USP <795> and USP <797> compounding standards. Several pharmacies in the state actively compound NMN, and out-of-state 503A pharmacies can also ship to Arkansas patients with a valid prescription.

Quality varies. Not all compounding pharmacies perform third-party purity testing on their NMN raw materials. Patients should ask three questions before filling a compounded NMN prescription: Does the pharmacy test each lot of NMN powder for identity and purity? Does it hold accreditation from the Pharmacy Compounding Accreditation Board (PCAB)? And does it provide a Certificate of Analysis (COA) on request?

Price ranges for compounded NMN in Arkansas break down by formulation:

• Oral capsules (250 mg daily): $50 to $90 per month
• Oral capsules (500 mg daily): $80 to $140 per month
• Sublingual troches (250 mg daily): $90 to $130 per month
• Sublingual troches (500 mg daily): $120 to $170 per month

These prices reflect 2026 data from Arkansas-licensed compounding pharmacies. Sublingual formulations cost more due to additional compounding steps and base ingredients, but they may offer better absorption. A 2022 pharmacokinetic study found that sublingual NMN delivery produced higher peak plasma NMN concentrations than oral capsules, though the clinical significance of this difference remains uncertain [8].

Telehealth Access for NMN/NR in Arkansas

Arkansas permits telehealth prescribing of NMN and NR. The Arkansas State Medical Board allows physicians and advanced practice providers to prescribe compounded medications after conducting a telehealth visit that meets the standard of care, including a medical history review and clinical assessment. No in-person visit is required for the initial prescription.

This matters for patients outside Little Rock and the northwest Arkansas corridor. Rural Arkansans who lack access to a local longevity medicine provider or compounding pharmacy can consult a telehealth physician, receive a prescription, and have compounded NMN shipped directly from a licensed 503A pharmacy. Several national telehealth platforms, including HealthRX, offer this service to Arkansas residents.

Telehealth visits for NMN typically cost $75 to $200 for an initial consultation and $50 to $100 for follow-up visits. Some platforms bundle the consultation fee into the cost of the medication, bringing the all-in monthly cost to $100 to $150 including the compounded NMN supply.

What the Clinical Evidence Actually Shows

Arkansas patients considering NMN or NR should understand what the clinical trial data supports and where it falls short. The evidence base is growing but still early-stage, with small sample sizes dominating the literature.

Yoshino et al. published the first randomized, placebo-controlled trial of NMN in humans in Science in 2021 (N=25). Postmenopausal women with prediabetes received 250 mg of NMN daily for 10 weeks. The NMN group showed a 25% improvement in skeletal muscle insulin sensitivity measured by hyperinsulinemic-euglycemic clamp, with no significant adverse events [9]. The effect on muscle insulin signaling was statistically significant (P<0.05), but the study was not powered to detect changes in fasting glucose or HbA1c.

For NR, the evidence base is somewhat larger. Martens et al. (2018) demonstrated that 1 to 000 mg daily of NR for six weeks raised whole-blood NAD+ by approximately 60% in healthy adults aged 55 to 79 [6]. A larger trial by Elhassan et al. (2019, N=40) confirmed that NR at 1 to 000 mg daily increased NAD+ metabolites in skeletal muscle and reduced circulating inflammatory cytokines in healthy older men [10].

Neither NMN nor NR has completed a Phase III clinical trial for any indication. The Endocrine Society has not issued guidelines on NAD+ precursor supplementation, and the American Academy of Anti-Aging Medicine (A4M) lists NMN and NR as "investigational" compounds with "promising but preliminary" human data [11]. Patients should approach marketing claims about cognitive enhancement, cardiovascular protection, or lifespan extension with appropriate skepticism.

Cost Comparison: NMN vs. NR vs. IV NAD+ in Arkansas

Three NAD+ precursor options are available to Arkansas residents, each with different cost structures and evidence profiles.

NMN (compounded, prescription): $50 to $140 per month depending on dose and formulation. Requires a prescription. Best evidence: improved muscle insulin sensitivity at 250 mg daily [9].

NR (over-the-counter, Niagen): $40 to $60 per month for 300 mg daily. No prescription required. Best evidence: 60% increase in blood NAD+ at 1 to 000 mg daily [6]. Available at major retail pharmacies statewide.

IV NAD+ infusions: $250 to $750 per session at Arkansas wellness clinics, typically administered as a 2- to 4-hour infusion of 250 to 500 mg. Sessions are usually recommended weekly or biweekly during an initial "loading" phase, then monthly. Annual costs can exceed $6,000. No randomized controlled trial has compared IV NAD+ to oral NMN or NR for any clinical endpoint.

For most Arkansas patients paying out of pocket, NR offers the best combination of cost, convenience, and supporting evidence. Compounded NMN becomes the stronger option for patients who want higher-dose NAD+ precursor therapy under medical supervision, particularly those with documented insulin resistance or metabolic dysfunction where the Yoshino et al. data is most relevant [9].

How to Reduce Your NMN/NR Costs in Arkansas

Several strategies can lower out-of-pocket spending for Arkansas residents.

Buy 90-day supplies. Most compounding pharmacies offer a 10% to 20% discount on three-month orders, dropping the effective NMN cost to $65 to $72 per month. Use HSA/FSA funds when a valid prescription exists for a documented medical condition. Compare compounding pharmacy prices, as markups vary by 30% to 50% across Arkansas pharmacies for the same formulation. Consider NR if cost is the primary concern, since it requires no prescription and retails for roughly half the price of compounded NMN.

Manufacturer discount cards and patient assistance programs do not exist for NMN because there is no FDA-approved branded product. ChromaDex, which manufactures Niagen (NR), occasionally offers promotional pricing through its direct-to-consumer website, but these discounts are modest (typically 10% to 15% on subscription orders) [5].

Arkansas does not operate a state-level prescription assistance program that covers compounded medications. The ARHealthConnect program and similar state initiatives are limited to FDA-approved drugs on the Medicaid formulary.